An interesting conversation on Twitter this afternoon with Andrew Ward (@ARWardMadrid) prompted me to think about whether Manchester City FC might be considered to have received State Aid. Our conversation was prompted by media reports that a number of European football clubs are being investigated by the EU Commission under the State Aid rules. Andrew’s […]
It has been almost a year since the Minimum Alcohol Price debate began in England and it is still an issue in the news. There is speculation that the UK Govt are about to drop their plans as a result of opposition in the cabinet and the Scottish Govts plans are being challenged before the […]
In October 2012 Christopher Brown posted an interesting blog on AG Kokott’s opinion in Case C-226/11 Expedia. The full judgment was delivered on 13 December 2012 and it seems appropriate to look at whether the Court followed the same line; or whether there was an ‘appreciable’ difference.
The Competition Law Scholars Forum, which is currently in its tenth year, has just announced a Call for Papers for its 1st International Conference, jointly hosted with the University of Luxembourg. The Conference will focus on competition law and State aid litigation.
Case C-441/11 Commission v Verhuzingen Coppens NV [2012] ECR I-0000 The Court of Justice, on 6 December 2012, delivered an interesting judgment examining the legal liability for a ‘bit player’ in a large cartel. The question whether a peripheral member of a cartel can be held liable for the whole infringement raises a number of […]
Anyone with an interest in competition law has a view on the work of Robert H Bork. His work has been undeniably influential; even for those, like me, who were never entirely convinced by the Chicago School way of thinking. In the introductory Chapter of our text book Barry Rodger and I refer on a […]
AstraZeneca AB v Commission (Case C-457/10 P) The Court of Justice of the EU delivered its judgment on 6 December 2012 on the appeal against the General Court’s judgment in Case T-321/05. This cases stems from a number of practices that AstraZeneca had adopted in the market for Proton Pump Inhibitors (‘PPIs’), a class of […]
This is the 1st Step in developing a new Competition Law blog primarily to support my teaching at Lancaster University Law School and the users of my Textbook, Competition Law and Policy in the EU and UK, published by Routledge and about to go into its 5th ed. I’ll be using the blog to discuss […]
